FLEURY (FLRY3) Main Indicators
Basic Data - FLRY3
| Company | FLEURY |
| Corporate Name | FLEURY S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | (i) prestação de serviços médicos e medicina diagnóstica; (ii) consultoria. assessoria. cursos. gestão de doenças crônicas; (iii) pesquisa e desenvolvimento; (iv) a prestação de serviços a terceiros |
| Share | FLRY3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 16.61 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 24.78 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICO2, ICON, IDIV, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 09/19/2024 | |
Relative Prices - FLRY3
| Price/Earnings | 15.22 |
| Price/SBV | 1.70 |
| Price/Net Sales | 1.22 |
| Price/CFO | 5.31 |
| Price/FCF | 6.93 |
| Price/Total Assets | 0.71 |
| Price/EBIT | 7.83 |
| Price/Working Capital | 3.80 |
| Price/NCAV | -1.80 |
| EV/EBIT | 12.27 |
| EV/EBITDA | 7.41 |
| EV/Net Sales | 1.91 |
| EV/CFO | 8.31 |
| EV/FCF | 10.86 |
| EV/Total Assets | 1.11 |
| Company Market Cap | R$ 9.09 B |
| Enterprise Value | R$ 14.23 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 16.61 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 4.52% |
| Updated 09/19/2024 | |
Income Statement - FLRY3
| Net Revenue | R$ 7.46 B |
| Gross Result | R$ 2.06 B |
| EBIT | R$ 1.16 B |
| Depreciation and Amortization | - R$ 759.40 M |
| EBITDA | R$ 1.92 B |
| Net Profit | R$ 597.02 M |
| Net Profit/Share | R$ 1.09 |
| Updated 08/08/2024 | |
| Net Revenue | R$ 1.98 B |
| Gross Result | R$ 567.32 M |
| EBIT | R$ 329.44 M |
| Depreciation and Amortization | - R$ 191.80 M |
| EBITDA | R$ 521.25 M |
| Net Profit | R$ 173.59 M |
| Profit/Share | R$ 0.32 |
| Updated 08/08/2024 | |
Price and Volume Behavior - FLRY3
| Lowest Price 52 weeks | R$ 13.58 |
| Highest Price 52 weeks | R$ 17.98 |
| Variation 2024 | -3.99% |
| Variation 1 year | 18.76% |
| Variation 2 years(total) | 10.70% |
| Variation 2 years(yearly) | 5.19% |
| Variation 3 years(total) | -17.79% |
| Variation 3 years(yearly) | -6.31% |
| Variation 4 years(total) | -30.31% |
| Variation 4 years(yearly) | -8.63% |
| Variation 5 years(total) | -15.28% |
| Variation 5 years(yearly) | -3.26% |
| Average Daily Volume (3 months) | R$ 44.81 M |
| Updated 09/19/2024 | |
Returns and Margins - FLRY3
| Return on Initial Tangible Capital | 16.86% |
| Return on Initial Invested Capital | 8.25% |
| Pre-Tax Return on Initial Tangible Capital | 25.54% |
| Pre-Tax Return on Initial Invested Capital | 12.50% |
| Return on Initial Shareholder´s Equity | 11.72% |
| Return on Initial Asset | 5.19% |
| Gross Margin | 27.63% |
| Net Margin | 8.01% |
| EBIT Margin | 15.56% |
| EBITDA Margin | 25.74% |
| Initial Asset Turnover | 0.65 |
| Financial Leverage | 2.39 |
| Liabilities/Net Worth | 1.39 |
| Net Debt/EBITDA | 2.68 |
| Updated 08/08/2024 | |
Balance Sheet - FLRY3
| Cash and Cash Equivalents | R$ 10.41 M |
| Total Assets | R$ 12.80 B |
| Short-Term Debt | R$ 593.82 M |
| Long-Term Debt | R$ 4.56 B |
| Gross Debt | R$ 5.16 B |
| Net Debt | R$ 5.15 B |
| Shareholder´s Equity | R$ 5.36 B |
| Share Book Value | R$ 9.79 |
| Common Shares | 547,191,026 |
| Preferred Shares | 0 |
| Total | 547,191,026 |
| Common Shares in Treasury | 1,601,287 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,601,287 |
| Common Shares (Except Treasury) | 545,589,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 545,589,739 |
| Updated 08/08/2024 | |
Cash Flow - FLRY3
| Operating Cash Flow | R$ 1.71 B |
| Cash Flow from Investments | - R$ 1.71 B |
| Financing Cash Flow | - R$ 21.37 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 21.10 M |
| Updated 08/08/2024 | |
| Operating Cash Flow | R$ 588.21 M |
| Cash Flow from Investments | - R$ 1.39 B |
| Financing Cash Flow | R$ 725.43 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 80.99 M |
| Updated 08/08/2024 | |
Experimental - FLRY3
| CAPEX 3 months | - R$ 97.63 M |
| Free Cash Flow 3 months | R$ 490.58 M |
| CAPEX 12 months | - R$ 402.07 M |
| Free Cash Flow 12 months | R$ 1.31 B |
| Updated 08/08/2024 | |